Related Experiment Videos
Structural bioinformatics study of PNP from Schistosoma mansoni
Nelson José Freitas da Silveira1, Hugo Brandão Uchôa, Fernanda Canduri
1Department of Physics, UNESP, São José do Rio Preto, SP 15054-000, Brazil.
Biochemical and Biophysical Research Communications
|August 18, 2004
Summary
Schistosoma mansoni purine nucleoside phosphorylase (PNP) structure was modeled to understand drug design. Differences in human and parasite PNP affinity for inosine were correlated with structural variations.
Area of Science:
- Parasitology and Structural Biology
- Drug Discovery and Medicinal Chemistry
Background:
- Schistosoma mansoni, a parasite causing schistosomiasis, relies on purine salvage pathways due to lacking de novo biosynthesis.
- Schistosomiasis is a major global health issue, second only to malaria in socioeconomic impact.
- Purine nucleoside phosphorylase (PNP) is a validated drug target for Schistosoma mansoni infections.
Purpose of the Study:
- To develop a structural model of Schistosoma mansoni PNP (SmPNP) complexed with inosine.
- To compare the structural and binding characteristics of SmPNP with human PNP (HsPNP).
- To correlate structural differences with observed variations in inosine binding affinity.
Main Methods:
- Homology modeling was employed using the crystal structure of human PNP-inosine complex as a template.
- The atomic coordinates of human PNP were used to build a structural model for S. mansoni PNP.
- Structural analysis focused on the complex of the modeled SmPNP with inosine.
Main Results:
- A structural model for the Schistosoma mansoni PNP-inosine complex (SmPNP-inosine) was successfully generated.
- Structural differences between SmPNP and human PNP were identified.
- These structural variations were correlated with distinct affinities for inosine binding between the two PNPs.
Conclusions:
- The generated SmPNP-inosine model provides insights into the structural basis for purine salvage in S. mansoni.
- Understanding these structural differences is crucial for the rational design of selective anti-schistosomiasis drugs targeting SmPNP.
- The study highlights the potential for structure-based drug design targeting parasitic PNP enzymes.